ZA941333B - Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides - Google Patents

Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides

Info

Publication number
ZA941333B
ZA941333B ZA941333A ZA941333A ZA941333B ZA 941333 B ZA941333 B ZA 941333B ZA 941333 A ZA941333 A ZA 941333A ZA 941333 A ZA941333 A ZA 941333A ZA 941333 B ZA941333 B ZA 941333B
Authority
ZA
South Africa
Prior art keywords
gamma
receptor
human interferon
chimeric human
immunoglobulin polypeptides
Prior art date
Application number
ZA941333A
Inventor
Zlatko Dembic
Gianni Garotta
Reiner Gentz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA941333B publication Critical patent/ZA941333B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/32Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
ZA941333A 1993-03-05 1994-02-25 Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides ZA941333B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93810170 1993-03-05

Publications (1)

Publication Number Publication Date
ZA941333B true ZA941333B (en) 1994-09-06

Family

ID=8214928

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA941333A ZA941333B (en) 1993-03-05 1994-02-25 Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides

Country Status (8)

Country Link
EP (1) EP0614981A1 (en)
JP (1) JPH06319552A (en)
CN (1) CN1094092A (en)
AU (1) AU5647894A (en)
CA (1) CA2114168A1 (en)
IL (1) IL108781A0 (en)
NZ (1) NZ250997A (en)
ZA (1) ZA941333B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5906816A (en) * 1995-03-16 1999-05-25 University Of Florida Method for treatment of autoimmune diseases
WO1994014467A1 (en) 1992-12-29 1994-07-07 Genentech, Inc. Treatment of inflammatory bowel disease with ifn-gamma inhibitors
JP2001521743A (en) * 1997-10-30 2001-11-13 コーネル リサーチ ファウンデーション、インコーポレイティッド Method of inhibiting immune response to recombinant vector
CU23229A1 (en) 2002-05-10 2007-09-26 Ct Ingenieria Genetica Biotech ANTH1 CHEMICAL ANTAGONIST
US7608430B2 (en) 2005-07-08 2009-10-27 Regeneron Pharmaceuticals, Inc. Interferon-γ antagonists and therapeutic uses thereof
JP5903051B2 (en) * 2010-02-18 2016-04-13 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Method for determining sequence variants of polypeptides
EP4342908A1 (en) * 2021-06-17 2024-03-27 Fapon Biotech Inc. Chimeric immunoglobulin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE132191T1 (en) * 1989-04-19 1996-01-15 Hoffmann La Roche DISSOLVABLE INTERFERON-GAMMA RECEPTORS AND METHOD FOR THE PRODUCTION THEREOF
IL91562A0 (en) * 1989-09-07 1990-04-29 Yeda Res & Dev Interferon-gamma receptor fragment and its production
WO1991016431A1 (en) * 1990-04-24 1991-10-31 Schering Corporation Soluble, truncated gamma-interferon receptors

Also Published As

Publication number Publication date
EP0614981A1 (en) 1994-09-14
NZ250997A (en) 1995-10-26
CN1094092A (en) 1994-10-26
IL108781A0 (en) 1994-05-30
JPH06319552A (en) 1994-11-22
CA2114168A1 (en) 1994-09-06
AU5647894A (en) 1994-09-08

Similar Documents

Publication Publication Date Title
ZA926962B (en) Chimaeric interleukin 5-recptor/immunoglobulin polypeptides.
GB9112553D0 (en) Fusion proteins
GB9325436D0 (en) Honeycomp heater
ZA948551B (en) Chimeric proteins comprising borrelia polypeptides; uses therefor
GB9200949D0 (en) Diagnostic peptides
PL313163A1 (en) Sealing element
GB9414833D0 (en) Polypeptide
ZA941333B (en) Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides
GB9208428D0 (en) Synthetic polypeptides
GB9324013D0 (en) Polypeptides
SG52708A1 (en) Chimeric receptor polypeptides human h13 proteins and uses thereof
NZ242056A (en) Cd4-like chimeric peptides
ZW9093A1 (en) Synthetic polypeptides
GB9319784D0 (en) Heater
IL100926A0 (en) Chimeric proteins
HU9200215V0 (en) Closing element
IL116044A0 (en) Chimeric proteins
EP0540512A4 (en) Chimeric hiv-1-neutralizing immunoglobulins
GB9324350D0 (en) Polypeptides
KR950014814U (en) Band heater
GB9313961D0 (en) Chimaeric proteins
GB9218056D0 (en) Polypeptides
GB9213437D0 (en) Polypeptides
GB9315249D0 (en) Antigen-binding proteins
GB9311296D0 (en) Synthetic polypeptides